Related Experiment Video
Updated: Aug 2, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Relationship between clock gene expression and CYP2C19 and CYP3A4 with benzodiazepines
Naoto Tani1,2, Tomoya Ikeda1,2, Takaki Ishikawa1,2
1Department of Legal Medicine, Graduate School of Medicine, Osaka Metropolitan University, Abeno, Osaka, Japan.
This study reveals how clock genes influence drug metabolism in patients taking benzodiazepines (BZDs). Lower expressions of DBP, CYP3A4, and CYP2C19 were observed in diazepam-exposed individuals, suggesting BZDs impact drug metabolism pathways.
Area of Science:
- Pharmacogenomics
- Chronobiology
- Drug Metabolism
Background:
- Benzodiazepines (BZDs) are widely prescribed, but their metabolism can vary significantly between individuals.
- Clock genes, integral to circadian rhythms, are increasingly recognized for their role in regulating drug-metabolizing enzymes.
- Understanding the interplay between BZDs, clock genes, and drug metabolism is crucial for optimizing therapeutic outcomes.
Purpose of the Study:
- To elucidate the expression patterns and functional roles of clock genes (BMAL1, PER2, DBP) in the context of benzodiazepine (BZD) drug metabolism.
- To identify drug metabolism regulators influenced by clock genes across different BZD types.
- To investigate the impact of BZD exposure on gene expression in both human liver samples and cell cultures.
Main Methods:
- Analysis of liver autopsy cases with confirmed BZD detection to examine the relationship between clock gene (BMAL1, PER2, DBP) and drug-metabolizing enzyme (CYP3A4, CYP2C19) expression.
- In vitro experiments using HepG2 human hepatocellular carcinoma cells to assess the effects of BZD exposure (diazepam, midazolam) on gene expression.
- Correlation analysis to determine relationships between specific clock genes and drug-metabolizing enzymes.
Main Results:
- Lower expression levels of DBP, CYP3A4, and CYP2C19 were observed in the liver of the diazepam-detected group compared to the non-detected group.
- A significant correlation was found between BMAL1 expression and CYP2C19 expression in autopsy samples.
- Cell culture experiments indicated that diazepam and midazolam exposure decreased DBP and CYP3A4 expression while increasing BMAL1 and CYP2C19 expression.
Conclusions:
- The study suggests that the clock gene DBP plays a regulatory role in CYP3A4 expression following benzodiazepine exposure.
- Findings indicate that clock genes and cytochrome P450 enzymes (CYPs) interact, influencing BZD metabolism.
- This research provides a foundation for understanding clock gene involvement in BZD metabolism, potentially paving the way for individualized drug therapy strategies.
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Circadian Rhythms and Gene Regulation
CNS Depressants: Barbiturates and Benzodiazepines
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...

